Pfizer agrees to let other companies produce its anti-viral COVID-19 pill, making it available in low-income countries

Pfizer has announced a partnership deal with a United Nations-backed group that will allow the widespread manufacture of its anti-COVID pill, opening up the treatment to 53% of the world's population in low- and middle-income countries.